Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with chronic kidney disease

Blood Coagulation and Fibrinolysis

Volumn 22, Issue 6, 2011, Pages 487-492

  Elshamaa, Manal F ^a   Sabry, Samar ^b   Badr, Ahmed ^b   El Ahmady, Mostafa ^a   Elghoroury, Eman A ^a   Thabet, Eman H ^a   Kandil, Dina ^a   Kamel, Solaf ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

CKD; DNA polymorphism; endothelial nitric oxide synthase; gene polymorphism; nitric oxide level

Indexed keywords

ENDOTHELIAL CONSTITUTIVE NITRIC OXIDE SYNTHASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CARDIOVASCULAR DISEASE; CHILD; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEMODIALYSIS; HETEROZYGOTE; HUMAN; HYPERTENSION; INTRON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ALLELES; CASE-CONTROL STUDIES; CHILD; EGYPT; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; INTRONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 80052082567     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0b013e328346ef71     Document Type: Article

References (29)

1. Tolins JP, Palmer RM, Moncada S, Raij L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 1990; 258:655-662.
2. Schmidt HH, Walter U. NO at work. Cell 1994; 78:919-925. (Pubitemid 24292320)
3. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 1997; 272:F561-F578.
4. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32:3-8. (Pubitemid 28324117)
5. Schmidt RJ, Baylis C. Total nitric oxide production is low in patients with chronic renal disease. Kidney Int 2000; 58:1261-1266.
6. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F. Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 1994; 198:1027-1033. (Pubitemid 24172800)
7. Wang Y, Kikuchi S, Suzuki H, Nagase S, Koyama A. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in nondiabetic renal diseases. Nephrol Dial Transplant 1999; 14:2898-2902.
8. Hibi K, Ishigami T, Tamura K, Mizushima S, Nyui N, Fujita T, et al. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998; 32:521-526; ecNOS gene polymorphism in renal failure 2305.
9. Buraczynska M, Ksiazek P, Zaluska W, Nowicka T, Ksiazek A. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrol Dial Transplant 2004; 19:2302-2306. (Pubitemid 39214125)
10. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266.
11. Kimura H, Gejyo F, Suzuki S, Yamaguchi T, Imura T, Miyazaki R, et al. Cholesteryl ester transfer protein gene mutation and vascular disease in dialysis patients. J Am Soc Nephrol 1999; 10:294-299. (Pubitemid 29068068)
12. Tsikas D. Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 2005; 39:797-815. (Pubitemid 40975073)
13. Salimi S, Firoozrai M, Nourmohammadi I, Shabani M, Mohebbi A. Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran. Indian J Med Res 2006; 124:683-688. (Pubitemid 46592109)
14. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden BW. Genetic analysis of nitric oxide and endothelin in end-stage renal disease. Nephrol Dial Transplant 2000; 15:1794-1800.
15. Kerkeni M, Letaief A, Achour A, Miled A, Trivin F, Maaroufi K. Endothelial nitric oxide synthetase, methylenetetrahydrofolate reductase polymorphisms, and cardiovascular complications in Tunisian patients with nondiabetic renal disease. Clin Biochem 2009; 42 (10-11):958-964.
16. Mö llsten A, Lajer M, Jorsal A, Tarnow L. The endothelial nitric oxide synthase gene and risk of diabetic nephropathy and development of cardiovasculardisease in type1 diabetes. Mol Genet Metab. 2009; 97:80-84; Epub 2009 Feb 3.
17. Nguyen-Khoa T, Massy ZA, de Bandt JP, Kebede M, Salama L, Lambrey G, et al. Oxidative stress and hemodialysis: role of inflammation and duration of dialysis treatment. Nephrol Dial Transplant 2001; 16:335-340. (Pubitemid 32123923)
18. Gururajan P, Gurumurthy P, Victor D, Srinivasa Nageswara Rao G, Sai Babu R, Sarasa Bharati A, Cherian KM. Plasma total nitric oxide and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphism: a study in a South Indian population. Biochem Genet 2010; 10528:9391-9397.
19. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995; 377:239-242.
20. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2:997-1000. (Pubitemid 19257913)
21. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 1993; 11:1375-1380. (Pubitemid 24008485)
22. Forte P, Copland M, Smith LM, Milne E, Sutherland J, Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997; 349:837-842. (Pubitemid 27129211)
23. Cotton JM, Kearney MT, Shah AM. Nitric oxide and myocardial function in heart failure: friend or foe? Heart 2002; 88:564-566. (Pubitemid 35418064)
24. Balat A, Cekmen M, Yurekli M, Yilmaz K, Sahinoz S. Adrenomodulin and nitrite in children with dilated cardiomyopathy. Pediatric Cardiol 2003; 24:381-385. (Pubitemid 37021439)
25. Fukuchi M, Hussain S, Giaid A. Heterogenous expression and activity of endothelial and inducible nitric oxide synthases in end stage human heart failure. Circulation 1998; 19:132-139.
26. Elshamaa MF, Sharaf EA, Farid YA, Elghoroury EA, Abdelghaffar E. Plasma nitric oxide level in myocardial disorders with left ventricular diastolic dysfunction. J Clin Basic Cardiol 2006; 9:Online 23-26.
27. Mitsuke Y, Lee JD, Shimizu H, Uzui H, Iwasaki H, Ueda T, Nitric oxide synthase activity in peripheral polymorphonuclear leukocytes in patients with chronic congestive heart failure. Am J Cardiol. 2001; 87: 183-187. (Pubitemid 32057229)
28. Thibaud D, Philippe R, Ajay M, Emmanuel C, Isabelle M, Hassenfuss G, et al. Increased neuronal nitric oxide synthase derived NO production in the failing human heart. Lancet 2004; 363:1365-1367.
29. Wasson S, Govindarajan G, Reddy HK, Flaker G. The role of nitric oxide and vasopressin in refractory right heart failure. J Cardiovascpharm Ther 2004; 9:9-11. (Pubitemid 38525752)